
Molecular Data MKD
Quarterly report 2019-Q4
added 08-19-2023
Molecular Data Accounts Receivables 2011-2025 | MKD
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Molecular Data
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 5.96 M | 20.4 M | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.4 M | 5.96 M | 13.2 M |
Quarterly Accounts Receivables Molecular Data
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 6.21 M | 7.9 M | - | 5.96 M | - | - | - | 20.4 M | - | - | - | 40.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 40.7 M | 5.96 M | 16.2 M |
Accounts Receivables of other stocks in the Chemicals industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Braskem S.A.
BAK
|
165 K | $ 2.84 | -2.91 % | $ 1.15 B | ||
|
Celanese Corporation
CE
|
1.12 B | $ 42.5 | -2.25 % | $ 4.64 B | ||
|
Ashland Global Holdings
ASH
|
242 M | $ 59.87 | 1.22 % | $ 2.75 B | ||
|
AdvanSix
ASIX
|
160 M | $ 16.02 | -1.66 % | $ 430 M | ||
|
Eastman Chemical Company
EMN
|
791 M | $ 63.83 | -0.68 % | $ 7.45 B | ||
|
DuPont de Nemours
DD
|
2.2 B | $ 40.67 | -0.66 % | $ 17 B | ||
|
Air Products and Chemicals
APD
|
1.9 B | $ 243.94 | 0.37 % | $ 54.3 B | ||
|
FutureFuel Corp.
FF
|
15 M | $ 3.35 | -0.45 % | $ 147 M | ||
|
Minerals Technologies
MTX
|
385 M | $ 62.39 | 0.91 % | $ 2 B | ||
|
Dow
DOW
|
4.76 B | $ 23.48 | -2.07 % | $ 16.5 B | ||
|
LSB Industries
LXU
|
38.8 M | $ 8.93 | 0.22 % | $ 643 M | ||
|
Tronox Holdings plc
TROX
|
266 M | $ 4.44 | -4.62 % | $ 701 M | ||
|
Valhi
VHI
|
326 M | $ 12.41 | -2.48 % | $ 354 | ||
|
Rayonier Advanced Materials
RYAM
|
214 M | $ 5.88 | -0.93 % | $ 387 M | ||
|
Univar Solutions
UNVR
|
1.49 B | - | -0.01 % | $ 5.99 B | ||
|
Westlake Chemical Partners LP
WLKP
|
20 M | $ 19.16 | -3.13 % | $ 674 M |